Vladimir Anikin

Harefield Hospital

Papers

1

Total Citations

88

H-Index

1

About

Vladimir Anikin is a leading thoracic surgeon and researcher whose work centers on minimally invasive surgical techniques for lung cancer, with a particular focus on improving patient recovery and quality of life. His most impactful contribution is the landmark VIOLET randomized controlled trial (2022, 88 citations), which rigorously compared video-assisted thoracoscopic surgery (VATS) lobectomy to traditional open lobectomy for early-stage lung cancer. This study provided high-quality evidence that VATS significantly enhances patient-reported physical function and recovery, reshaping clinical practice by demonstrating that minimal-access surgery reduces tissue trauma without compromising oncologic outcomes. Anikin’s research bridges the gap between surgical innovation and patient-centered care, emphasizing functional recovery as a key metric of success. His work has been instrumental in advancing thoracic surgery toward less invasive approaches, directly influencing guidelines and surgical decision-making worldwide. With a career dedicated to evidence-based surgical oncology, Anikin continues to drive improvements in lung cancer management, making him a pivotal figure for students and researchers interested in thoracic surgery, perioperative outcomes, and the integration of patient-reported measures into clinical trials.

Research Focus

Key Achievements

1
H-Index
1
Papers
88
Total Citations
88
Avg Citations/Paper
🏆 Most Cited Paper
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT
88 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Harefield Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago